Article citationsMore>>

Kyriakopoulos, C., Chen, Y., Carducci, M., Liu, G., Jarrard, D. et al. (2018) Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survval Analysis of the Randomized Phase 3 E3805 CHAARTED Trial. Journal of Clinical Oncology, 36, 1080-1087.
https://doi.org/10.1200/JCO.2017.75.3657

has been cited by the following article:

• TITLE: Aminated Cyclopropylmethylphosphonates as Potent Prostate Cancer Inhibitors

  AUTHORS: Abed Al Aziz Al Quntar, Ibrahim Abasy

  KEYWORDS: Prostate Cancer, Cancer, Cyclopropylphophonates, Aminophosphonates, Cyclopropanes, Phosphonates, Alkynylphosphonates, Anti-Cancer, Prostate

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.7, July 23, 2024

  ABSTRACT: Inspired by the anti-pancreatic promising results of our novel aminated cyclopropylmethylphosphonate compounds, an in vitro anti-prostate cancer activity exploration of these compounds was carried out on human prostate cancer cell line PC-3, and showed potent inhibiting activity at low micromolar concentrations (with an IC50 of approximately 45 μM).